Research ArticleAsian Journal of Biological and Life SciencesVol. 13 | Issue 1 | pp. 48–60Open access
Novel Drug Development for Anti-Cholesterol Activity by in silico Analysis: Identification Cholesterol Inhibiting Compounds
- 1,
- 2,
- 3*
- 1 Department of Information Technology, K. J. Somaiya Institute of Technology, Mumbai, Maharashtra, INDIA.
- 2 Genolites Research and Development Laboratory, Coimbatore, Tamil Nadu, INDIA.
- 3 Basic Science and Humanities Department, K. J. Somaiya Institute of Technology, Mumbai, Maharashtra, INDIA.
Published in Asian Journal of Biological and Life Sciences
Correspondence: Thulasi G Pillai
Basic Science and Humanities Department, K. J. Somaiya Institute of Technology, Mumbai, Maharashtra, INDIA.
Email: thulasi@somaiya.edu
- Received:
- Sep 27, 2024
- Accepted:
- Nov 12, 2024
- DOI:
- 10.5530/ajbls.2024.13.7
How to cite
Kura, A. M., KarukuvelRaja, R., & Pillai, T. G. Novel Drug Development for Anti-Cholesterol Activity by in silico Analysis: Identification Cholesterol Inhibiting Compounds. Asian Journal of Biological and Life Sciences, 13(1), 48–60. https://doi.org/10.5530/ajbls.2024.13.7
Abstract
Aim: Cholesterol is required for cellular metabolism and steroid hormone production. However, the excessive level leads to the condition known as hypercholesterolemia, which causes cardiovascular illnesses. A number of drugs can lower blood cholesterol levels, but these medications have a variety of negative effects. The microalgae possess wide range of bioactive compounds, which would be used to treat the abnormal cholesterol levels. Materials and Methods: This study aims to determine the anticholesterol activity of bioactive compounds of the selected microalgal species (Chlorella, Anabaena, Oscillatoria, and Lyngbya) via in silico study. Druglikeness analysis were carried out for the 226 compounds, based upon the results 81 compounds were selected for molecular docking. Results: The ADMET analysis and PASS prediction was performed for the 5 best docked compounds such as Debromoaplysiatoxin, Spiroidesin, Oscillatoxin A, Ergosta-8,(9)14-dien-3beta-ol, and Cyclindrospermopsin. Conclusion: Hence, these compounds can be used to develop the novel cholesterol lowering drugs.
Keywords
Subject
Article metadata
| Title | Novel Drug Development for Anti-Cholesterol Activity by in silico Analysis: Identification Cholesterol Inhibiting Compounds |
|---|---|
| Authors | Ananya M Kura; R KarukuvelRaja; Thulasi G Pillai |
| Affiliations | Department of Information Technology, K. J. Somaiya Institute of Technology, Mumbai, Maharashtra, INDIA.; Genolites Research and Development Laboratory, Coimbatore, Tamil Nadu, INDIA.; Basic Science and Humanities Department, K. J. Somaiya Institute of Technology, Mumbai, Maharashtra, INDIA. |
| Corresponding author | thulasi@somaiya.edu |
| Journal | Asian Journal of Biological and Life Sciences |
| Volume / Issue | Vol. 13, Issue 1 |
Also in this issue
- An Insight into the Host-Pathogen Interactions between Macrophage and Different Microbial Species: A Detailed Approachpp. 1–8
- Navigating Biologics Regulation: A Deep Dive into Australian Compliancepp. 9–21
- A Systematic Review of the Role Played by Aquaporins in the Etiology of Rheumatoid Arthritispp. 27–34
- Phytochemical Screening and in vitro Antibacterial Activity of Hibiscus rosa-sinensis L. Leaf Extractspp. 35–39
- Biotic Stress Response of Local Host on Cassava Mosaic Virus and its Control with selected Essential Oils: An Experimental Approachpp. 71–78